Core Viewpoint - Four social security fund portfolios are collectively trapped in a leading company that claims to have broken the overseas monopoly, with its stock price plummeting from 104 yuan to around 20 yuan, a decline of 80% over three years [1][3]. Group 1: Company Performance - The company has broken a 30-year overseas monopoly in three key areas, achieving over 60% market share in domestic palladium carbon catalysts for chloroacetic acid, and facilitating the mercury-free transformation of domestic acetylene-based PVC production lines with gold-based catalysts [3]. - Despite its technological strengths, the company reported a net profit decline from 1.13 billion yuan in 2023 to 930 million yuan in 2024, primarily due to falling precious metal prices and increased depreciation and personnel costs from new project launches [3]. - The company holds over a hundred patents and has established deep ties with leading industry players, which may have attracted social security funds to invest [3]. Group 2: Market Trends - A significant number of previously high-performing stocks in the A-share market have seen their prices halved, with 26 stocks that had profits exceeding 1 billion yuan experiencing declines of over 50% from their 2021 peaks [4]. - The valuation bubble burst is identified as the primary driver of this downturn, with companies like China Duty Free and Longi Green Energy experiencing drastic declines in stock prices due to inflated valuations and industry cycle reversals [6]. - The market has shifted away from traditional blue-chip stocks, favoring those with popular concepts, policy support, or short-term elasticity, leading to a collective sell-off of white horse stocks [11]. Group 3: Social Security Fund Strategy - Social security funds, traditionally viewed as "smart money" in the A-share market, have collectively been trapped in 31 leading stocks that have seen continuous declines over three years, with an average price-to-earnings ratio of around 10 times [6]. - The funds have been observed to buy into stocks at declining prices, often leading to deeper losses, as seen in the case of stocks like Shede Spirits and Mindray Medical [7][8]. - The social security fund's investment strategy emphasizes asset rebalancing, maintaining a value investment philosophy despite current market challenges [12].